Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
Stocks in this Quantisnow insightIndustrials
Historical context for EVGN
Across the 8 sessions after earlier EVGN headlines, the stock closed higher 3 times and lower 5 times, with a median move of 3.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | EVGN | SPY |
|---|---|---|---|
| Feb 10, 2026 | Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™ | -7.3% | -0.3% |
| Feb 9, 2026 | Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board | +0.9% | +0.5% |
| Feb 4, 2026 | Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer | +4.8% | -0.5% |
| Jan 7, 2026 | Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders | -0.9% | -0.3% |
| Dec 30, 2025 | Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development | -3.2% | -0.1% |
| Nov 20, 2025 | Evogene Reports Third Quarter 2025 Financial Results | -7.7% | -1.5% |
Keep researching EVGN
Quantisnow market dataNASDAQ
EVGN
Evogene Ltd
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Agricultural Chemicals
Get push alerts for EVGN
Full EVGN profile on Quantisnow Follow EVGN and get a push notification the moment its next story breaks.